Market Size of United States Insulin Drugs And Delivery Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 19.70 Billion |
| Market Size (2029) | USD 22.5 Billion |
| CAGR (2024 - 2029) | 2.70 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
US Insulin Drugs & Delivery Devices Market Analysis
The United States Insulin Drugs And Delivery Devices Market size is estimated at USD 19.70 billion in 2024, and is expected to reach USD 22.5 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).
Since the start of the pandemic, the United States has recorded 79 million cases of COVID-19. According to CDC data, the average number of new COVID-19 cases per day has decreased to 40,000. In January 2021, after the FDA had authorized COVID-19 vaccines for emergency use the month before, people in the United States began to be vaccinated. By March, the daily number of new infections had steeply declined, and April through June witnessed those numbers go down even further. But by July, the arrival and spread of the delta coronavirus variant sparked another surge in cases of COVID-19.
Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized and, thus, incur more healthcare expenses compared to non-diabetic people. In general, people with diabetes are more likely to experience severe symptoms and complications when infected with a virus. According to the AACE (American Association of Clinical Endocrinologists), recent studies have shown that of those hospitalized for severe disease, 22.2-26.9% reported living with diabetes. Diabetes and high glucose levels are associated with increased complications, respiratory failure, and mortality in hospitalized patients with coronavirus.
As they combine the medication and syringe in one handy unit, insulin pens can make administering insulin more convenient. Pens, instead of syringes, are pre-filled with insulin, including premixed insulins. They are rather easy to use: twist or snap on a fresh needle, dial a dose, and inject the insulin. Then, discard the spent needle into a sharps receptacle that is needle-safe. When the insulin in a particular pen runs out or expires, you should throw it away. However, other insulin pens can be reused once a fresh insulin cartridge is installed.
